Swiss drugmaker Roche got a fourthquarter lift from its COVID19 test business, where higher sales offset a decline at its drugs unit whose revenue was dragged down by the pandemic and patentexpired cancer drugs that lost ground to rivals. from Top Business News- News18.com Read The Rest:timesnownews...
No comments: